However, the predictive performance for cystoid macular edema (CME) was relatively unsatisfactory, probably due to the insensitivity of CME patients to anti-VEGF drugs and the sample limitations of our dataset. The gene discussed is VEGFA; the disease is Cystoid macular dystrophy.